{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:07:36Z","timestamp":1768712856998,"version":"3.49.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR068157"],"award-info":[{"award-number":["AR068157"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR070091"],"award-info":[{"award-number":["AR070091"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR079298"],"award-info":[{"award-number":["AR079298"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG062334"],"award-info":[{"award-number":["AG062334"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Laboratory Research & Development Service","award":["BX005851"],"award-info":[{"award-number":["BX005851"]}]},{"name":"Biomedical Laboratory Research & Development Service","award":["BX004813"],"award-info":[{"award-number":["BX004813"]}]},{"name":"Biomedical Laboratory Research & Development Service","award":["BX004835"],"award-info":[{"award-number":["BX004835"]}]},{"name":"Biomedical Laboratory Research & Development Service","award":["AG036675"],"award-info":[{"award-number":["AG036675"]}]},{"DOI":"10.13039\/100006379","name":"VA Office of Research and Development","doi-asserted-by":"publisher","award":["BX000105"],"award-info":[{"award-number":["BX000105"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Immune reconstitution bone loss (IRBL) is a common side-effect of antiretroviral therapy (ART) in people with human immunodeficiency virus (PWH). Immune reconstitution bone loss acts through CD4+ T-cell\/immune reconstitution-induced inflammation and is independent of antiviral regimen. Immune reconstitution bone loss may contribute to the high rate of bone fracture in PWH, a cause of significant morbidity and mortality. Although IRBL is transient, it remains unclear whether bone recovers, or whether it is permanently denuded and further compounds bone loss associated with natural aging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used a validated IRBL mouse model involving T-cell reconstitution of immunocompromised mice. Mice underwent cross-sectional bone phenotyping of femur and\/or vertebrae between 6 and 20 months of age by microcomputed tomography (\u00b5CT) and quantitative bone histomorphometry. CD4+ T cells were purified at 20 months to quantify osteoclastogenic\/inflammatory cytokine expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Although cortical IRBL in young animals recovered with time, trabecular bone loss was permanent and exacerbated skeletal decline associated with natural aging. At 20 months of age, reconstituted CD4+ T cells express enhanced osteoclastogenic cytokines including RANKL, interleukin (IL)-1\u03b2, IL-17A, and tumor necrosis factor-\u03b1, consistent with elevated osteoclast numbers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Immune reconstitution bone loss in the trabecular compartment is permanent and further exacerbates bone loss due to natural aging. If validated in humans, interventions to limit IRBL may be important to prevent fractures in aging PWH.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiab631","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T20:11:14Z","timestamp":1640290274000},"page":"38-48","source":"Crossref","is-referenced-by-count":7,"title":["Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model"],"prefix":"10.1093","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-5748","authenticated-orcid":false,"given":"M Neale","family":"Weitzmann","sequence":"first","affiliation":[{"name":"Atlanta Department of Veterans Affairs Medical Center , Decatur, Georgia , USA"},{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Vikulina","sequence":"additional","affiliation":[{"name":"Atlanta Department of Veterans Affairs Medical Center , Decatur, Georgia , USA"},{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Roser-Page","sequence":"additional","affiliation":[{"name":"Atlanta Department of Veterans Affairs Medical Center , Decatur, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanglun","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University , Augusta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan E","family":"McGee-Lawrence","sequence":"additional","affiliation":[{"name":"Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University , Augusta, Georgia , USA"},{"name":"Department of Orthopaedic Surgery, Medical College of Georgia, Augusta University , Augusta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia Ling","family":"Tu","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, San Francisco VA Healthcare System, University of California , San Francisco, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhan","family":"Chang","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, San Francisco VA Healthcare System, University of California , San Francisco, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ighovwerha","family":"Ofotokun","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"},{"name":"Grady Healthcare System , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"2022081210482455800_jiab631-CIT0001","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population.","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s40506-017-0109-9","article-title":"Bone loss in HIV infection.","volume":"9","author":"Moran","year":"2017","journal-title":"Curr Treat Options Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1138\/20110486","article-title":"HIV and low bone density: responsible party, or guilty by association?","volume":"8","author":"Bolland","year":"2011","journal-title":"IBMS BoneKEy"},{"key":"2022081210482455800_jiab631-CIT0004","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/QAD.0000000000002563","article-title":"Immature\/transitional B-cell expansion is associated with bone loss in HIV-infected individuals with severe CD4+ T-cell lymphopenia.","volume":"34","author":"Titanji","year":"2020","journal-title":"AIDS"},{"key":"2022081210482455800_jiab631-CIT0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/QAD.0000000000001764","article-title":"T-cell receptor activator of nuclear factor-kappaB ligand\/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.","volume":"32","author":"Titanji","year":"2018","journal-title":"AIDS"},{"key":"2022081210482455800_jiab631-CIT0006","doi-asserted-by":"crossref","first-page":"e1004497","DOI":"10.1371\/journal.ppat.1004497","article-title":"Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection.","volume":"10","author":"Titanji","year":"2014","journal-title":"PLoS Pathog"},{"key":"2022081210482455800_jiab631-CIT0007","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1073\/pnas.1003020107","article-title":"Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.","volume":"107","author":"Vikulina","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022081210482455800_jiab631-CIT0008","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and pathophysiological bone turnover - role of the immune system.","volume":"12","author":"Weitzmann","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2022081210482455800_jiab631-CIT0009","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"2022081210482455800_jiab631-CIT0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0011","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers.","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0012","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-1293.2010.00864.x","article-title":"Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.","volume":"12","author":"Hansen","year":"2011","journal-title":"HIV Med"},{"key":"2022081210482455800_jiab631-CIT0013","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/ciw331","article-title":"A single-dose zoledronic acid infusion prevents antiretroviral therapy-induced bone loss in treatment-naive HIV-infected patients: a phase IIb trial.","volume":"63","author":"Ofotokun","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0014","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022081210482455800_jiab631-CIT0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000-2006.","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0016","doi-asserted-by":"crossref","first-page":"e17217","DOI":"10.1371\/journal.pone.0017217","article-title":"Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.","volume":"6","author":"Womack","year":"2011","journal-title":"PLoS One"},{"key":"2022081210482455800_jiab631-CIT0017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/QAI.0000000000000674","article-title":"Increased fracture incidence in middle-aged HIV-infected and HIV-uninfected women: updated results from the women\u2019s interagency HIV study.","volume":"70","author":"Sharma","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022081210482455800_jiab631-CIT0018","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jbmr.1874","article-title":"HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study.","volume":"28","author":"Guerri-Fernandez","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2022081210482455800_jiab631-CIT0019","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/QAI.0000000000000112","article-title":"HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study.","volume":"66","author":"Prieto-Alhambra","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022081210482455800_jiab631-CIT0020","first-page":"385","article-title":"HIV and bone metabolism.","volume":"11","author":"Ofotokun","year":"2011","journal-title":"Discov Med"},{"key":"2022081210482455800_jiab631-CIT0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11904-011-0099-z","article-title":"HIV: inflammation and bone.","volume":"9","author":"Ofotokun","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2022081210482455800_jiab631-CIT0022","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"2022081210482455800_jiab631-CIT0023","volume-title":"14th Conference on Retroviruses and Opportunistic Infections","author":"Tebas"},{"key":"2022081210482455800_jiab631-CIT0024","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022081210482455800_jiab631-CIT0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QAI.0b013e31820cf010","article-title":"Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.","volume":"56","author":"Piso","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022081210482455800_jiab631-CIT0026","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0000000000000918","article-title":"Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection.","volume":"30","author":"Ofotokun","year":"2016","journal-title":"AIDS"},{"key":"2022081210482455800_jiab631-CIT0027","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/cid\/cit538","article-title":"Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.","volume":"57","author":"Grant","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0028","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1038\/ncomms9282","article-title":"Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.","volume":"6","author":"Ofotokun","year":"2015","journal-title":"Nat Commun"},{"key":"2022081210482455800_jiab631-CIT0029","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/infdis\/jix444","article-title":"Homeostatic expansion of CD4+ T cells promotes cortical and trabecular bone loss, whereas CD8+ T cells induce trabecular bone loss only.","volume":"216","author":"Weitzmann","year":"2017","journal-title":"J Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","article-title":"HIV and aging.","volume":"53","author":"Wing","year":"2016","journal-title":"Int J Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0031","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/B978-012369454-6\/50074-1","volume-title":"The Mouse in Biomedical Research","author":"Flurkey","year":"2007","edition":"2nd ed"},{"key":"2022081210482455800_jiab631-CIT0032","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/art.38319","article-title":"CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.","volume":"66","author":"Roser-Page","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2022081210482455800_jiab631-CIT0033","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/bloodadvances.2018027557","article-title":"Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.","volume":"3","author":"Weitzmann","year":"2019","journal-title":"Blood Adv"},{"key":"2022081210482455800_jiab631-CIT0034","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mehy.2010.09.023","article-title":"Inflammaging: the driving force in osteoporosis?","volume":"76","author":"Lencel","year":"2011","journal-title":"Med Hypotheses"},{"key":"2022081210482455800_jiab631-CIT0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/498511","article-title":"Bone disease and HIV infection.","volume":"42","author":"Amorosa","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0036","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection.","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"2022081210482455800_jiab631-CIT0037","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/ciz1027","article-title":"Antiretroviral therapy-induced bone loss is durably suppressed by a single dose of zoledronic acid in treatment-naive persons with HIV infection: a phase IIB trial.","volume":"71","author":"Ofotokun","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022081210482455800_jiab631-CIT0038","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/COH.0000000000000260","article-title":"The protease inhibitors and HIV-associated bone loss.","volume":"11","author":"Moran","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2022081210482455800_jiab631-CIT0039","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"2022081210482455800_jiab631-CIT0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","article-title":"Correlates of osteoprotegerin levels in women and men.","volume":"13","author":"Khosla","year":"2002","journal-title":"Osteoporos Int"},{"key":"2022081210482455800_jiab631-CIT0041","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00198-004-1699-x","article-title":"Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.","volume":"16","author":"Indridason","year":"2005","journal-title":"Osteoporos Int"},{"key":"2022081210482455800_jiab631-CIT0042","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/ar974","article-title":"Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation.","volume":"5","author":"Goronzy","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"2022081210482455800_jiab631-CIT0043","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria.","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"2022081210482455800_jiab631-CIT0044","doi-asserted-by":"crossref","first-page":"E8141","DOI":"10.1073\/pnas.1617460113","article-title":"Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice.","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022081210482455800_jiab631-CIT0045","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1016\/S2352-3018(17)30032-2","article-title":"Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised","volume":"4","author":"DeJesus","year":"2017","journal-title":"Lancet HIV"},{"key":"2022081210482455800_jiab631-CIT0046","doi-asserted-by":"crossref","first-page":"E2556","DOI":"10.1073\/pnas.1713370115","article-title":"Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.","volume":"115","author":"Raynaud-Messina","year":"2018","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab631\/42361142\/jiab631.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/1\/38\/45379022\/jiab631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/1\/38\/45379022\/jiab631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T10:59:44Z","timestamp":1660301984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/226\/1\/38\/6485936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,28]]},"published-print":{"date-parts":[[2022,8,12]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab631","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2021,12,28]]}}}